November 23, 2020 · STOCK Act disclosure
Representative Michael T. McCaul (Republican-TX) bought Neurocrine Biosciences, Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on November 23, 2020 and was disclosed on January 7, 2021 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.